Clinical Trial Update: Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of docetaxel and oxaliplatin in metastatic transitional cell carcinoma of the urothelial tract has completed, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transitional Cell Carcinoma of the Urothelial Tract

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Leonard Appleman | Conditions: Metastatic Transitional Cell Cancer of the Urothelial Tract | Phase 2 | Status: COMPLETED | Results posted: 2017-08-11